Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
AIM 15 March 2021 NOTICE 15/03/2021 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON Pursuant to AIM Rule 41 the following securities have been cancelled from trading on AIM...
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...
Phimedix PLC 03 March 2021 3 March 2021 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY...
ng Kong-based metal recycling company - Says it is in early-stage acquisition discussions with a company in the life s ...
Phimedix PLC 18 January 2021 18 January 2021 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...
The following is a round-up of earnings of London-listed companies, issued on Tuesday and not separately reported by ...
Phimedix PLC 08 December 2020 8 December 2020 Phimedix Plc (Formerly Zibao Metals Recycling Holdings Plc) ("Phimedix" or the "Company") Half Year Results Phimedix Plc (AIM:...
Phimedix PLC 05 October 2020 5 October 2020 Phimedix Plc ("Phimedix" or "the Company") Result of Annual General Meeting The Board of Phimedix is pleased to announce the...
sh shell - Trading in shares temporarily suspended under AIM rule 15, which requires companies to make an acquisition ...
Phimedix PLC 14 September 2020 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
